Treo Ventures is a venture capital firm established in 2018 and located in Santa Clara, California. The firm focuses on investing in companies within the medical technology, digital health, and therapeutic sectors, primarily targeting opportunities in the United States, Ireland, and Europe. Treo Ventures is a Registered Investment Adviser and is known for its experienced team, which brings over 50 years of collective expertise in healthcare investing and operations. The firm has a strong commitment to supporting innovative healthcare companies that are developing novel technologies to enhance patient care and outcomes.
ShiraTronics develops neuromodulation therapies to treat chronic migraine by delivering continuous stimulation to targeted nerves to relieve, interrupt, and prevent migraine episodes. Founded in 2018 and based in Ireland, the company maintains an additional location in Minneapolis, Minnesota, and pursues innovative neuromodulation technology to address unmet neurological needs and improve patient outcomes.
ShiraTronics
Series A in 2019
ShiraTronics develops neuromodulation therapies to treat chronic migraine by delivering continuous stimulation to targeted nerves to relieve, interrupt, and prevent migraine episodes. Founded in 2018 and based in Ireland, the company maintains an additional location in Minneapolis, Minnesota, and pursues innovative neuromodulation technology to address unmet neurological needs and improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.